A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Clinical trial NCT07340827 · RECRUITING
Trial details
- NCT number
- NCT07340827
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-04
- Primary completion
- 2028-07-05
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.